Aspira Pathlab & Diagnostics Ltd - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligation & Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2021.

Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure on Related Party Transactions, on standalone basis, drawn in accordance with applicable accounting standards for the half-year ended September 30, 2021.